Authors : Sakarie Mustafe Hidig, Hannan Samtar, Fidele Kakule Kitaghenda, Mohamed Abdifatah Mohamed
DOI : 10.61186/rabms.11.1.19
Volume : 11
Issue : 1
Year : 2025
Page No : 19-31
Background & Aims: Hepatocellular carcinoma (HCC) is a major global health concern, ranking sixth among prevalent cancers worldwide and third in cancer-related deaths. Despite diagnostic advancements, prognosis remains challenging. Traditional methods rely on postoperative pathology, limiting preoperative decision-making. Radiomics offers a solution by extracting imaging data to predict outcomes before surgery, aiding personalized treatment decisions. Materials & Methods: A PubMed search spanning from May 2019 to June 2024 was conducted to identify relevant peer-reviewed articles using the keywords: "radiomics," "MRI," "hepatocellular carcinoma," "HCC," "radiomics features," "liver cancer imaging," "tumor segmentation," "treatment response," and "HCC prognosis." The search yielded a total of 850 articles. After an initial screening based on titles and abstracts, 150 full-text articles were reviewed, and 35 articles were selected for inclusion in this review. The review focused on highlighting the utility of radiomics features on MRI across various aspects of HCC management. Results: This review highlights MRI radiomics' extensive utility in managing HCC. It aids in diagnosis, treatment decision-making, and prognosis prediction by analyzing imaging data noninvasively. MRI radiomics informs differential diagnosis, histological grading, microvascular invasion assessment, gene expression prediction, therapeutic monitoring, and prognostic evaluation. Its transformative potential offers clinicians a comprehensive toolset for personalized care and improved patient outcomes in HCC management. Conclusion: MRI radiomics holds promise as a noninvasive tool for improving the diagnosis and treatment of HCC. Its ability to extract comprehensive imaging data enables clinicians to make personalized treatment decisions, potentially improving patient outcomes. Further research and clinical validation are warranted to fully integrate MRI radiomics into routine clinical practice for HCC management.